Keywords: alexion, randomization, eculizumab, trial, complete, pharmaceuticals, usa

Alexion: randomization in eculizumab trial complete

Article | 08 August 2005

Print This

Alexion Pharmaceuticals of the USA says it has completed randomization of its pivotal Phase III efficacy trial, TRIUMPH, which is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in